Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma

Published:2016-10-21 Issue:3 Volume:24 Page:850-859
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Komatsu Hisateru,Iguchi Tomohiro,Masuda Takaaki,Hirata Hidenari,Ueda Masami,Kidogami Shinya,Ogawa Yushi,Sato Kuniaki,Hu Qingjiang,Nambara Sho,Saito Tomoko,Sakimura Shotaro,Uchi Ryutaro,Ito Shuhei,Eguchi Hidetoshi,Sugimachi Keishi,Eguchi Hidetoshi,Doki Yuichiro,Mori Masaki,Mimori Koshi

Funder

Japan Society for the Promotion of Science

OITA Cancer Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-016-5573-9.pdf

Reference28 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.

2. Katagiri S, Yamamoto M. Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus. Surg Today. 2014;44:219–26.